Ditto
Provides AI-enabled health tools that help patients understand medical guidance and support menstrual-health users.
Overview
Ditto is a Rotterdam-based AI healthcare company described in funding announcements as a female-led menstrual health startup. Its product focus is framed around making it easier for people to answer “what did the doctor say?”, indicating a patient-facing approach to health understanding and care navigation. The company targets consumers and patients seeking clearer medical guidance, with menstrual health as a stated focus area. Ditto raised an undisclosed €8M round in May 2026 and a $6M seed round in July 2026 led by FoodLabs and Eka Ventures.
Funding History
FoodLabs and Eka Ventures lead $6M seed round for female-led menstrual health startup DITTO
Rotterdam’s Ditto raises €7.6 million to make “what did the doctor say?” easier to answer
Frequently Asked Questions
- How much funding does AI Funding track for Ditto?
- AI Funding tracks $6M + €8M for Ditto across 2 funding rounds in this database.
- Who are Ditto's investors?
- Ditto's investors include Heal Capital, Optiverder, Rubio Impact Ventures.
- What does Ditto do?
- Ditto is a Rotterdam-based AI healthcare company described in funding announcements as a female-led menstrual health startup. Its product focus is framed around making it easier for people to answer “what did the doctor say?”, indicating a patient-facing approach to health understanding and care navigation. The company targets consumers and patients seeking clearer medical guidance, with menstrual health as a stated focus area. Ditto raised an undisclosed €8M round in May 2026 and a $6M seed round in July 2026 led by FoodLabs and Eka Ventures.
- Where is Ditto headquartered?
- Ditto is headquartered in Rotterdam, Netherlands.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.